Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022
BackgroundEvolution of SARS-CoV-2 is continuous.AimBetween 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity.MethodsIn nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined. Patients' demographic and clinical details were recorded. Associations between mild/moderate or severe COVID-19 and SARS-CoV-2 variants and patient characteristics were assessed by logistic regression. Rates and genomic locations of mutations, as well as quasi-species distribution (≥ 2 heterogeneous positions, ≥ 50× coverage) were estimated based on 1,332 high-quality sequences.ResultsOverall, 11 SARS-CoV-2 clades infected 1,762 study patients of median age 59 years (interquartile range (IQR): 45-73), with 52.5% (n = 925) being male. In total, 101 non-synonymous substitutions/insertions correlated with disease prognosis (severe, n = 27; mild-to-moderate, n = 74). Several hotspots (mutation rates ≥ 85%) occurred in Alpha, Delta, and Omicron variants of concern (VOCs) but none in pre-Alpha strains. Four hotspots were retained across all study variants, including spike:D614G. Average number of mutations per open-reading-frame (ORF) increased in the spike gene (average < 5 per genome in January 2020 to > 15 in 2022), but remained stable in ORF1ab, membrane, and nucleocapsid genes. Quasi-species were most prevalent in 20A/EU2 (48.9%), 20E/EU1 (48.6%), 20A (38.8%), and 21K/Omicron (36.1%) infections. Immunocompromised status and age (≥ 60 years), while associated with severe COVID-19 or death irrespective of variant (odds ratio (OR): 1.60-2.25; p ≤ 0.014), did not affect quasi-species' prevalence (p > 0.05).ConclusionSpecific mutations correlate with COVID-19 severity. Quasi-species potentially shaping VOCs' emergence are relevant to consider.
Authors
- Anna Górska (ORCID: https://orcid.org/0000-0003-3305-8711)
- Alex W. Friedrich (ORCID: https://orcid.org/0000-0003-4881-038X)
- Veerle Matheeussen (ORCID: https://orcid.org/0000-0003-2137-2068)
- Elisa Gentilotti (ORCID: https://orcid.org/0000-0001-6018-5295)
- Erley Lizarazo (ORCID: https://orcid.org/0000-0003-2749-9780)
- Mathias Smet
- Aline-Marie Florence
- Benoît Visseaux (ORCID: https://orcid.org/0000-0002-9279-5538)
- Jade Ghosn (ORCID: https://orcid.org/0000-0003-2914-959X)
- Coretta van Leer‐Buter (ORCID: https://orcid.org/0000-0002-4072-7373)
- Surbhi Malhotra‐Kumar (ORCID: https://orcid.org/0000-0001-8699-8905)
- Cédric Laouenan (ORCID: https://orcid.org/0000-0002-3681-6314)
- Matilda Berkell (ORCID: https://orcid.org/0000-0002-7096-7896)
- Fulvia Mazzaferri (ORCID: https://orcid.org/0000-0002-3907-108X)
- Charlotte Charpentier (ORCID: https://orcid.org/0000-0002-6441-7054)
- Delphine Bachelet (ORCID: https://orcid.org/0000-0003-0547-008X)
- Maddalena Giannella (ORCID: https://orcid.org/0000-0001-8273-7601)
- Mariana Guedes (ORCID: https://orcid.org/0000-0002-0681-3091)
- Natascia Caroccia (ORCID: https://orcid.org/0000-0003-2931-2107)
- Jesús Rodríguez‐Baño (ORCID: https://orcid.org/0000-0001-6732-9001)
- Zaira R. Palacios‐Baena (ORCID: https://orcid.org/0000-0002-1713-6807)
- Samir Kumar‐Singh (ORCID: https://orcid.org/0000-0001-9466-6732)
- Evelina Tacconelli
- Anna Maria Franco-Yusti
Institutions
- Université Claude Bernard Lyon 1 (FR)
- University of Verona (IT)
- University Medical Center Groningen (NL)
- University of Antwerp (BE)
- Inserm (FR)
- University of Groningen (NL)
- Université Paris Cité (FR)
- Instituto de Salud Carlos III (ES)
- Sorbonne Université (FR)
- Université Sorbonne Paris Nord (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Nord (FR)
- Media Working Group (US)
- Azienda USL di Bologna (IT)
- Instituto de Biomedicina de Sevilla (ES)
- Hôpital Bichat-Claude-Bernard (FR)
- Metropolitan University (BD)
- Universidad de Sevilla (ES)
- University of Bologna (IT)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2025-03-13
- DOI
- https://doi.org/10.2807/1560-7917.es.2025.30.10.2400038
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40